These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3002268)

  • 21. Isolation and characterization of an arildone-resistant poliovirus 2 mutant with an altered capsid protein VP1.
    Eggers HJ; Rosenwirth B
    Antiviral Res; 1988; 9(1-2):23-35. PubMed ID: 2839108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of WIN 51711 and R 78206 as stabilizers of poliovirus virions and procapsids.
    Rombaut B; Andries K; Boeyé A
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2153-7. PubMed ID: 1716654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stabilisation of poliovirus with pirodavir.
    Rombaut B; Andries K; Boeyé A
    Dev Biol Stand; 1996; 87():173-80. PubMed ID: 8854015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral agents against picornaviruses.
    Eggers HJ
    Antiviral Res; 1985; Suppl 1():57-65. PubMed ID: 3002267
    [No Abstract]   [Full Text] [Related]  

  • 25. An improved synthesis of the anti-picornavirus flavone 3-O-methylquercetin.
    Boers F; Deng BL; Lemière G; Lepoivre J; De Groot A; Dommisse R; Vlietinck AJ
    Arch Pharm (Weinheim); 1997 Oct; 330(9-10):313-6. PubMed ID: 9396391
    [No Abstract]   [Full Text] [Related]  

  • 26. Protein kinase activity in purified poliovirus particles and empty viral capsid preparations.
    Schärli CE; Koch G
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():129-39. PubMed ID: 6319565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects of 3-methylquercetin.
    Laekeman GM; Claeys M; Rwangabo PC; Herman AG; Vlietinck AJ
    Planta Med; 1986 Dec; (6):433-7. PubMed ID: 3562658
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro inhibitory effects of dual combinations of picornavirus replication inhibitors.
    Nikolaeva L; Galabov AS
    Acta Virol; 1999 Oct; 43(5):303-11. PubMed ID: 10757231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stabilization by host cell components and Mg2+ of the neutralization epitopes of poliovirus.
    Rombaut B; Vrijsen R; Boeyé A
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():303-7. PubMed ID: 2578552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antiviral compound 5-(3,4-dichlorophenyl) methylhydantoin inhibits the post-synthetic cleavages and the assembly of poliovirus in a cell-free system.
    Verlinden Y; Cuconati A; Wimmer E; Rombaut B
    Antiviral Res; 2000 Oct; 48(1):61-9. PubMed ID: 11080541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic analysis of the effect of poliovirus receptor on viral uncoating: the receptor as a catalyst.
    Tsang SK; McDermott BM; Racaniello VR; Hogle JM
    J Virol; 2001 Jun; 75(11):4984-9. PubMed ID: 11333877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-picornavirus activity of synthetic flavon-3-yl esters.
    Conti C; Mastromarino P; Sgro R; Desideri N
    Antivir Chem Chemother; 1998 Nov; 9(6):511-5. PubMed ID: 9865389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus late protein synthesis is resistant to the inhibition of translation induced by poliovirus.
    Castrillo JL; Carrasco L
    J Biol Chem; 1987 May; 262(15):7328-34. PubMed ID: 3034890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dominant drug targets suppress the emergence of antiviral resistance.
    Tanner EJ; Liu HM; Oberste MS; Pallansch M; Collett MS; Kirkegaard K
    Elife; 2014 Nov; 3():. PubMed ID: 25365453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a capsid-stabilizing pyridazinamine, R 78206, on the eclipse and intracellular location of poliovirus.
    Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
    J Virol; 1993 Apr; 67(4):2367-9. PubMed ID: 8383247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dichloroflavan (BW683C) on the stability and uncoating of rhinovirus type 1B.
    Tisdale M; Selway JW
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():97-105. PubMed ID: 6092321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Presence of isorhamnetin 3-glucoside and 3-rutinoside in Sambucus nigra L. flowers].
    Lamaison JL; Petitjean-Freytet C; Carnat A
    Ann Pharm Fr; 1991; 49(5):258-62. PubMed ID: 1841526
    [No Abstract]   [Full Text] [Related]  

  • 38. An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.
    Dove AW; Racaniello VR
    J Virol; 2000 Apr; 74(8):3929-31. PubMed ID: 10729171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present.
    Mosser AG; Rueckert RR
    J Virol; 1993 Mar; 67(3):1246-54. PubMed ID: 8382293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro antiviral activity of single domain antibody fragments against poliovirus.
    Thys B; Schotte L; Muyldermans S; Wernery U; Hassanzadeh-Ghassabeh G; Rombaut B
    Antiviral Res; 2010 Aug; 87(2):257-64. PubMed ID: 20566349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.